[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356145-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356145-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","combined-pathological-response-and-pepi-score-improves-long-term-prognostic-stratification-in-hr-positive-breast-cancer-following-neoadjuvant-endocrine-therapy","Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy","","Neoadjuvant endocrine therapy (NET) is increasingly used for hormone receptor (HR)-positive breast cancer, yet reliable methods to predict long-term outcomes remain limited. This retrospective study assessed the prognostic value of pathological response and the preoperative endocrine prognostic index (PEPI), and tested whether their combination improves risk stratification. Among 160 postmenopausal patients receiving NET, both pathological response and PEPI were associated with relapse, distant relapse, and breast cancer-specific survival.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/combined-pathological-response-and-pepi-score-improves-long-term-prognostic-stratification-in-hr-positive-breast-cancer-following-neoadjuvant-endocrine-therapy/356145/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/combined-pathological-response-and-pepi-score-improves-long-term-prognostic-stratification-in-hr-positive-breast-cancer-following-neoadjuvant-endocrine-therapy/356145.png","ImageObject",300,407,{"name":42,"@type":43},"hdkawk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the study?","Question",{"text":63,"@type":64},"To evaluate whether pathological response and the preoperative endocrine prognostic index (PEPI) can predict long-term outcomes after NET in HR-positive breast cancer, and to determine if combining them improves risk stratification.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were pathological response and PEPI used in the analysis?",{"text":68,"@type":64},"Pathological response was graded using the Miller & Payne system, while PEPI scores were calculated from post-treatment tumor characteristics; survival outcomes including RFS, DDFS, and BCSS were then analyzed.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about the combined prognostic model?",{"text":72,"@type":64},"The combination of pathological response and PEPI showed superior long-term prognostic performance compared with either approach alone, and low-risk patients identified by the combined model had excellent 10-year survival outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356145,1790169282,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","doi: 10.21873/invivo.14452  \nCombined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy  \nMIN YING1*, ZHAOQING FAN1*, YINGJIAN HE1, MENG QI1, BIN DONG2, AIPING LU2, JINFENG LI1, YUNTAO XIE1, TIANFENG WANG1, BENYAO LIN1 and TAO OUYANG1  \n1 Breast Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Cancer Prevention & Treatment Center, Peking University Cancer Hospital & Institute, Beijing, P. R. China; 2 Pathological Department, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Cancer Prevention & Treatment Center, Peking University Cancer Hospital & Institute, Beijing, P. R. China  \nAbstract  \nBackground/Aim: Neoadjuvant endocrine therapy (NET) is increasingly used in hormone receptor (HR)-positive breast cancer; however, optimal methods for predicting long-term outcomes remain limited. This study aimed to evaluate the prognostic value of pathological response and preoperative endocrine prognostic index (PEPI), and to assess whether their combination improves risk stratification.  \nPatients and Methods: A total of 160 postmenopausal patients with strongly HR-positive breast cancer (T1-3N0-1M0) treated with NET were retrospectively analyzed. Pathological response was assessed using the Miller & Payne grading system. PEPI scores were calculated based on post-treatment tumor characteristics. Survival outcomes, including relapsefree survival (RFS), distant disease-free survival (DDFS), and breast cancer-specific survival (BCSS), were analyzed. Results: With a median follow-up of 113 months, pathological response was independently associated with improved RFS, DDFS, and BCSS (all p\u003C0.05). Patients with a PEPI score of 0-1 showed significantly better long-term outcomes compared to those with higher scores. Importantly, the combination of pathological response and PEPI demonstrated superior prognostic performance (78.1%) compared with either method alone. Patients identified as low-risk by the combined model exhibited excellent 10-year survival outcomes.  \nConclusion: The integration of pathological evaluation with PEPI scoring provides a simple and clinically applicable approach for prognostic stratification in HR-positive breast cancer following NET. This combined model may help identify patients who could safely avoid adjuvant chemotherapy, supporting individualized treatment strategies.  \nKeywords: Breast cancer, pathological evaluation, neoadjuvant endocrine therapy, long-term outcome, individualized treatment, preoperative endocrine prognostic index.  \n*These Authors contributed equally to this study.  \n✉ Tao Ouyang, Breast Cancer Prevention & Treatment Center, Peking University Cancer Hospital & Institute, 100142 Beijing,  \nP. R. China. Tel: +86 01088197830, [e-mail:](e-mail: Breastcenter66@163.com)[ Breastcenter66@163.com](e-mail: Breastcenter66@163.com)  \nReceived April 8, 2026 | Revised May 20, 2026 | Accepted May 26, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Published by the International Institute of Anticancer Research.  \nIntroduction  \nOver the past decade (2010 to 2019), breast cancer-the most common malignant tumor among women-hasseena sustained global increase in incidence, rising by 0.5% annually (1, 2). Hormone receptor (HR)-positive breast cancer, as the predominant subtype of breast cancer, accounts for approximately 60% to 70% of all breast cancer cases (3) . Its treatment strategies and prognostic assessment have consistently been a primary focus of clinical research. Endocrine therapy is widely accepted asthe standard adjuvant treatment for HR-positive breast cancer. Neoadjuvant endocrine therapy (NET) has alread","cbCaifxwDJn1R64d","https://ap.wps.com/l/cbCaifxwDJn1R64d","pdf",1827310,14,"English","# Background/Aim\n# Patients and Methods\n## Patient enrollment\n## Pathological response assessment\n## PEPI calculation and survival analyses\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To evaluate whether pathological response and the preoperative endocrine prognostic index (PEPI) can predict long-term outcomes after NET in HR-positive breast cancer, and to determine if combining them improves risk stratification.\"},{\"question\":\"How were pathological response and PEPI used in the analysis?\",\"answer\":\"Pathological response was graded using the Miller \\u0026 Payne system, while PEPI scores were calculated from post-treatment tumor characteristics; survival outcomes including RFS, DDFS, and BCSS were then analyzed.\"},{\"question\":\"What did the study find about the combined prognostic model?\",\"answer\":\"The combination of pathological response and PEPI showed superior long-term prognostic performance compared with either approach alone, and low-risk patients identified by the combined model had excellent 10-year survival outcomes.\"}]","Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy | PDF",1790123628,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c41ed0444cee9dec16ad5d6f13c0f084.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0de2c275ff6de426ec87dc0caf50435.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aeced3a4b2da9ad4f4162f900fce162c.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/277a0362fdf5a9055cc72ce1ac38ff3e.webp",980,1306]